Assembly Biosciences, Inc. (ASMB) stock
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)
Close on Nov 17, 2026Market cap $458.11MP/E –Yield –
Assembly Biosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Assembly Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$38.48M. For fiscal 2025 it was -$41.09M. The highest annual figure on record is $22.74M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$41.09M | – |
| FY2024 | Dec 31, 2024 | -$51.12M | -324.8% |
| FY2023 | Dec 31, 2023 | $22.74M | – |
| FY2022 | Dec 31, 2022 | -$84.46M | – |
| FY2021 | Dec 31, 2021 | -$93.40M | – |
| FY2020 | Dec 31, 2020 | -$62.96M | – |
| FY2019 | Dec 31, 2019 | -$84.07M | – |
| FY2018 | Dec 31, 2018 | -$64.96M | -3592.4% |
| FY2017 | Dec 31, 2017 | $1.86M | – |
| FY2016 | Dec 31, 2016 | -$34.88M | – |
| FY2015 | Dec 31, 2015 | -$18.70M | – |
| FY2014 | Dec 31, 2014 | -$14.97M | – |
| FY2013 | Dec 31, 2013 | -$17.80M | – |
| FY2012 | Dec 31, 2012 | -$21.38M | – |
| FY2011 | Dec 31, 2011 | -$25.07M | – |
| FY2010 | Dec 31, 2010 | -$5.21M | – |
| FY2009 | Dec 31, 2009 | -$3.48M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.49M | – |
| Q1 FY2026 | Mar 31, 2026 | -$22.10M | – |
| Q4 FY2025 | Dec 31, 2025 | $14.24M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.13M | – |
| Q2 FY2025 | Jun 30, 2025 | -$16.76M | – |
| Q1 FY2025 | Mar 31, 2025 | -$23.44M | – |
| Q4 FY2024 | Dec 31, 2024 | -$407.00K | -100.6% |
| Q3 FY2024 | Sep 30, 2024 | -$15.24M | – |
| Q2 FY2024 | Jun 30, 2024 | -$17.10M | – |
| Q1 FY2024 | Mar 31, 2024 | -$18.36M | – |
| Q4 FY2023 | Dec 31, 2023 | $73.65M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.85M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.63M | – |
| Q1 FY2023 | Mar 31, 2023 | -$23.43M | – |
| Q4 FY2022 | Dec 31, 2022 | -$19.25M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.82M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.89M | – |
| Q1 FY2022 | Mar 31, 2022 | -$27.50M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$18.88M | -277.4% |
| Q2 FY2021 | Jun 30, 2021 | -$21.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$33.34M | – |
| Q4 FY2020 | Dec 31, 2020 | -$25.27M | – |
| Q3 FY2020 | Sep 30, 2020 | $10.65M | – |
| Q2 FY2020 | Jun 30, 2020 | -$23.12M | – |
| Q1 FY2020 | Mar 31, 2020 | -$25.22M | – |
| Q4 FY2019 | Dec 31, 2019 | -$20.53M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.60M | – |
| Q2 FY2019 | Jun 30, 2019 | -$21.01M | – |
| Q1 FY2019 | Mar 31, 2019 | -$23.94M | – |
| Q4 FY2018 | Dec 31, 2018 | -$16.73M | – |
| Q3 FY2018 | Sep 30, 2018 | -$16.68M | – |
| Q2 FY2018 | Jun 30, 2018 | -$16.05M | – |
| Q1 FY2018 | Mar 31, 2018 | -$15.50M | -144.4% |
| Q4 FY2017 | Dec 31, 2017 | -$9.77M | – |
| Q3 FY2017 | Sep 30, 2017 | -$10.96M | – |
| Q2 FY2017 | Jun 30, 2017 | -$12.36M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.94M | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.04M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.86M | – |
See a number that looks wrong?